CVRX Key Statistics, Chart & Performance
The current stock price of CVRX is 7.61 USD. In the past month the price decreased by -22.66%. In the past year, price decreased by -42.22%.
CVRX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 24.96 | 216.56B | ||
| ISRG | INTUITIVE SURGICAL INC | 67.05 | 204.67B | ||
| BSX | BOSTON SCIENTIFIC CORP | 32.57 | 142.45B | ||
| SYK | STRYKER CORP | 26.94 | 135.69B | ||
| BDX | BECTON DICKINSON AND CO | 13.57 | 55.85B | ||
| IDXX | IDEXX LABORATORIES INC | 54.11 | 54.48B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.55 | 50.04B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 18.15 | 37.95B | ||
| RMD | RESMED INC | 24.71 | 35.70B | ||
| DXCM | DEXCOM INC | 35.95 | 26.08B | ||
| PODD | INSULET CORP | 62.47 | 20.08B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.05 | 17.72B |
Related stock screener links
About CVRX
Company Profile
CVRx, Inc. engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company is headquartered in Minneapolis, Minnesota and currently employs 206 full-time employees. The company went IPO on 2021-06-30. The firm is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The firm's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
Company Info
CVRX INC
9201 West Broadway Avenue, Suite 650
Minneapolis MINNESOTA US
CEO: Nadim Yared
Employees: 206
Phone: 17634162850
CVRX INC / CVRX FAQ
Can you describe the business of CVRX INC?
CVRx, Inc. engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company is headquartered in Minneapolis, Minnesota and currently employs 206 full-time employees. The company went IPO on 2021-06-30. The firm is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The firm's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
What is the stock price of CVRX INC today?
The current stock price of CVRX is 7.61 USD. The price decreased by -2.69% in the last trading session.
Does CVRX stock pay dividends?
CVRX does not pay a dividend.
What is the ChartMill technical and fundamental rating of CVRX stock?
CVRX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
How is the market expecting CVRX stock to perform?
13 analysts have analysed CVRX and the average price target is 11.73 USD. This implies a price increase of 54.14% is expected in the next year compared to the current price of 7.61.
What is the employee count for CVRX stock?
CVRX INC (CVRX) currently has 206 employees.
What is CVRX INC worth?
CVRX INC (CVRX) has a market capitalization of 199.46M USD. This makes CVRX a Micro Cap stock.
CVRX Technical Analysis
CVRX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CVRX. Both the profitability and financial health of CVRX have multiple concerns.
CVRX Financial Highlights
Over the last trailing twelve months CVRX reported a non-GAAP Earnings per Share(EPS) of -2.02. The EPS increased by 25.19% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -46.73% | ||
| ROE | -108.26% | ||
| Debt/Equity | 1.03 |
CVRX Forecast & Estimates
13 analysts have analysed CVRX and the average price target is 11.73 USD. This implies a price increase of 54.14% is expected in the next year compared to the current price of 7.61.
For the next year, analysts expect an EPS growth of 22.86% and a revenue growth 10.14% for CVRX